Endotension: The Silent Threat in Aortic Aneurysm Repair
"Unveiling the complexities of endotension after endovascular aneurysm repair (EVAR) and how it leads to rupture."
For patients with aortic aneurysms who are not candidates for conventional surgery or standard endovascular procedures, a new technique called 'chimney' is considered. This approach involves placing stents through the visceral and renal branches of the aorta during endovascular aneurysm repair (EVAR).
The 'chimney' technique is used when open surgery carries significant risks because the aneurysm affects the renal and visceral vessels. It involves deploying covered stents parallel to the main aortic stent-graft to maintain blood flow to vital side branches.
While EVAR has become a routine procedure, it isn't without potential complications. One of the most common of these is an endoleak, where blood flow persists within the excluded aneurysm sac, pressurizing it and increasing the risk of rupture. This article will guide you through understanding of endoleaks and endotension, and the best ways to protect yourself.
Why It Matters
Endotension describes a concerning post-repair pattern in which an aneurysm sac may continue to enlarge despite no visible endoleak. Its clinical importance lies in the possibility that apparently successful repair may still require prolonged assessment. Because definitions and reported outcomes vary, the condition should be interpreted cautiously and in the context of ongoing imaging follow-up.
EVAR and Its Limits
Endovascular aneurysm repair (EVAR) changed the treatment of abdominal aortic aneurysms by reducing perioperative morbidity and mortality compared with standard open repair, but it introduced its own complications. Endotension was initially proposed to describe enlargement of the aneurysm sac after EVAR without a demonstrable endoleak. The term remains controversial, and both its causes and treatment protocols are debated. One report specifically examined a nonoperative approach in five patients, underscoring that operative treatment is not universally accepted.
From Ligation to EVAR
The history of aneurysm treatment spans more than 2,000 years and parallels major advances in medicine. The second-century physician Antyllus provided an early record of aneurysm cause and treatment, while Osler highlighted his proximal and distal ligation technique. More recent development moved from open surgical intervention toward minimally invasive endovascular repair technology. The evolution of endotension belongs to this later period, emerging as a controversial term associated with post-EVAR aneurysm-sac enlargement without a demonstrable endoleak.
What is Endotension?
An endoleak is a complication of EVAR, maintaining flow and pressure within the excluded aneurysm sac. Endoleaks are classified into five types based on their mechanisms and locations.
- Type I: Occurs at the proximal or distal attachment sites of the endograft, indicating an incomplete seal.
- Type II: Results from retrograde flow into the aneurysm sac via branch vessels like the lumbar or inferior mesenteric arteries.
- Type III: Involves leaks due to graft defects, disconnection of graft components, or tears in the graft material.
- Type IV: Characterized by graft porosity, where blood permeates through the graft fabric itself.
- Type V (Endotension): Aneurysm sac expansion without a detectable leak, often due to increased pressure transmitted through the thrombus lining the sac.
An Evolving Evidence Base
Current research continues to examine how endotension should be defined, detected, and managed after endovascular aneurysm repair. Reviews suggest that uncertainty remains substantial because reported definitions, proposed mechanisms, and treatment approaches are not fully consistent. As a result, clinical interpretation generally depends on longitudinal imaging and the individual patient's risk profile.
The Cost of Uncertainty
Endotension, often described as a type V endoleak, remains controversial because studies use variable definitions and report a range of treatments. Although the rupture risk associated with aneurysm-sac expansion without a defined endoleak may be relatively low, one review emphasizes that annual rupture risk increases significantly after four years of surveillance. The same review therefore stresses long-term annual surveillance and multiple imaging studies. A 2025 retrospective single-center study further illustrates the management challenge by examining long-term outcomes and rupture risk among 19 patients with endotension.
Balancing Repair Strategies
Comparisons between endovascular and open aneurysm repair must account for more than the initial procedure. EVAR offers important perioperative advantages, but its long-term success depends on surveillance for complications such as endoleak, device migration, and aneurysm-sac behavior. Endotension illustrates why a less invasive repair does not eliminate the need for extended follow-up. Because definitions and treatment evidence vary, direct comparisons of outcomes require careful interpretation.
Navigating the Shadows of Endotension
The development of aneurysm sac expansion due to endotension remains a diagnostic challenge, even with advanced imaging techniques. Because endotension lacks visible leaks, it requires a high degree of clinical suspicion and often is diagnosed by exclusion. Continued research into new diagnostic methods, such as implantable pressure sensors, is essential to improving outcomes and reducing the risk of rupture in patients undergoing EVAR.
A Persistent Clinical Puzzle
The available material presents endotension as a recognized but unsettled complication after EVAR. The central clinical problem is aneurysm-sac enlargement without a demonstrable endoleak, a pattern that may reflect mechanisms not captured by routine terminology. Management remains debated, ranging from observation in selected cases to further intervention. Long-term imaging is therefore central to evaluating whether the condition is stable or progressing.
Better Surveillance, Better Evidence
Future work is likely to focus on improving long-term surveillance and clarifying which patients require reintervention. EVAR is described as the established first-line treatment for anatomically suitable abdominal aortic aneurysms, but its long-term success depends on detecting complications such as endoleak and device migration. A systematic review of 13 non-randomized studies published from 2005 through 2024 included 22,118 EVAR patients and identified 209 cases of endotension, estimating an occurrence rate of 1.6% with a 95% confidence interval of 0.9% to 2.3%. These findings support continued efforts to standardize definitions and strengthen evidence for follow-up and treatment decisions.
Beyond the Visible Leak
Endotension can create a diagnostic challenge because pressure or sac expansion may occur without visible leakage. In a retrospective series, 12 patients underwent open repair for endotension between January 2005 and October 2018; these patients came from a group of 708 who had undergone EVAR, and their mean age was 76.1 years, with a range of 66 to 88. The study reviewed aortic anatomy, surgical findings, procedural complications, and mortality. This experience highlights how uncommon and complex cases may ultimately require individualized assessment and treatment.
Living With Uncertainty
For patients, endotension can mean continued monitoring even when routine evaluation does not show an obvious leak. The uncertainty surrounding its causes and treatment may make follow-up a continuing part of life after aneurysm repair. Decisions about observation or further intervention must account for changing imaging findings and the patient's clinical circumstances. Clear communication is important because a seemingly successful repair does not necessarily end the need for surveillance.